Previous 10 | Next 10 |
Berkeley Lights (NASDAQ:BLI) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open. The consensus EPS Estimate is -$0.26 (-36.8% Y/Y) and the consensus Revenue Estimate is $22.05M (+1.6% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revis...
EMERYVILLE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24, 2022. Comp...
EMERYVILLE, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually from Fe...
RADNOR, PA / ACCESSWIRE / January 16, 2022 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Berkeley Lights, Inc. ("Berkeley Lights") (NASDAQ:BLI) . The action charges Berkeley Lights with violations o...
EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster...
Thursday was an eventful day for digital cell biology company Berkeley Lights (NASDAQ: BLI) ... but not in a good way. Following news of a c-suite departure and a business update, investors aggressively sold off the company's stock. At the end of the day, the shares suffered a steep...
Berkeley Lights Inc ( NASDAQ: BLI ) went down 30% after announcing its Chief Executive Officer, Dr. Eric Hobbs will be moving from CEO and a member of the company’s BoD to the Antibody Therapeutics department president. Berkeley Lights is now in search of a new Chief ...
EMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI), (“BLI” or “the Company”), a leader in digital cell biology, today announced that Eric D. Hobbs, Ph.D. will transition from his role as chief executive officer (CEO) and me...
EMERYVILLE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will be participating virtually in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Berkeley Lights management is schedul...
Radnor, Pennsylvania--(Newsfile Corp. - January 2, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Berkeley Lights, Inc. ("Berkeley Lights") (NASDAQ: BLI). The action charges Berkeley Lights ...
News, Short Squeeze, Breakout and More Instantly...
Berkeley Lights Inc. Company Name:
BLI Stock Symbol:
NASDAQ Market:
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company PR Newswire PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif. , March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: B...
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire EMERYVILLE, Calif. , Feb. 23, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter ...
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 PR Newswire EMERYVILLE, Calif. , Feb. 13, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that the Com...